TAXUS PERSEUS Small Vessel

PHASE3CompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

October 31, 2013

Conditions
Coronary Artery Disease
Interventions
DEVICE

Percutaneous Coronary Intervention (PCI) with paclitaxel-eluting stent (TAXUS Element) implantation

TAXUS Element stent implantation

Trial Locations (28)

10021

Lenox Hill Hospital, New York

10032

Columbia University Medical Center, New York

13088

St. Joseph's Hospital Health Center, Liverpool

19010

Main Line Health Heart Center, Bryn Mawr

25701

St. Mary's Medical Center, Huntington

27401

LeBauer Cardiovascular Research Foundation, Greensboro

27610

Wake Medical Center, Raleigh

34471

Mediquest Research at Munroe Regional Medical Center, Ocala

45219

The Christ Hospital, Cincinnati

49770

Cardiac & Vascular Research Center of Northern Michigan, Petoskey

62701

St. John's Hospital, Springfield

68526

Nebraska Heart Hospital, Lincoln

73120

Oklahoma Foundation for Cardiovascular Research, Oklahoma City

78229

TexSAn Heart Hospital, San Antonio

92037

Scripps Clinic, La Jolla

93301

Bakersfield Memorial Hospital, Bakersfield

98104

Swedish Medical Center, Seattle

99204

Sacred Heart Medical Center, Spokane

35235-3401

Medical Center East, Birmingham

19718-0002

Christiana Hospital, Newark

34239-2940

Sarasota Memorial Hospital, Sarasota

46804-4140

Northern Indiana Research Alliance / Lutheran Hospital of Indiana, Fort Wayne

04102

Maine Medical Center, Portland

55407-1195

Abbott Northwestern Hospital, Minneapolis

28203-5866

Carolinas Medical Center, Charlotte

27157-0001

Wake Forest University School of Medicine, Winston-Salem

43214-3907

Riverside Methodist Hospital, Columbus

77030-2767

Methodist DeBakey Heart Center, Houston

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY